BioDuro-Sundia vs GemPharmatech

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/bioduro-sundia/gempharmatech

Category	BioDuro-Sundia	GemPharmatech
Listed site	cro	cro
Summary	Integrated CRDMO with 30 years of expertise spanning discovery chemistry, biology, DMPK, and IND-enabling development for small and large molecules, plus API and drug product manufacturing.	GemPharmatech develops and supplies genetically engineered mouse models (GEMMs) and preclinical research services using CRISPR/Cas9 and gene-editing technologies, with a library of 25,000+ mouse strains including KO/cKO, humanized, and immunodeficient models.
Services	Discovery Research Target Identification & Validation High-Throughput Screening Computational & In-Silico Drug Discovery Medicinal Chemistry In Vitro Pharmacology In Vitro ADME / DMPK Safety Pharmacology Genetic Toxicology Preclinical In Vitro Studies In Vivo Efficacy Models In Vivo PK / PD Studies GLP Toxicology Specialized & Large-Animal Models Preclinical In Vivo Studies Bioanalysis Biomarker Assays Flow Cytometry Services Analytical Method Development & Validation ICH Stability Studies Translational Research US FDA Regulatory Strategy China NMPA Regulatory Strategy Regulatory Affairs	Specialized & Large-Animal Models In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vivo Studies In Vitro Pharmacology Preclinical In Vitro Studies Target Identification & Validation
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Antibody-Drug Conjugate (ADC) Peptide	Biologics (Monoclonal Antibodies)
Indications	Oncology Immunology Neurology Metabolic Respiratory	Oncology Metabolic Cardiovascular Immunology Neurology Infectious Disease Rare Disease
Locations	Headquarters, Irvine, California, United States	Headquarters, Jiangsu, China
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.